Literature DB >> 1323346

Effects of actin filaments on fibrin clot structure and lysis.

P A Janmey1, J A Lamb, R M Ezzell, S Hvidt, S E Lind.   

Abstract

The muscle and cytoskeletal protein actin is released from cells as a consequence of cell death and interacts with components of the hemostatic and fibrinolytic systems, including platelets, plasmin, and fibrin. We report here that incorporation of actin filaments into fibrin clots changes their viscoelastic properties by increasing their shear modulus at low deforming stresses and by nearly eliminating their tendency to become more rigid with increasing deformation (ie, exhibit strain-hardening). The viscoelastic effects depended on the length of the actin filaments as shown by the effects of the plasma filament-severing protein, gelsolin. Binding of actin to fibrin clots also varied with actin filament length. The plasma actin-binding proteins gelsolin and vitamin D-binding protein reduced, but did not eliminate, the incorporation of actin in the clot. Fluorescence microscopy showed a direct association of rhodamine-labeled actin filaments with the fibrin network. Incubation of clots containing long actin filaments in solutions containing physiologic concentrations of gelsolin (2 mumol/L) released 60% of the actin trapped in the clot. Reduction of the actin content of a fibrin clot by incubation in a gelsolin-containing solution resulted in an increased rate of clot lysis. The ability of plasma gelsolin to shorten actin filaments may therefore be of physiologic and potentially of therapeutic importance insofar as gelsolin-mediated diffusion of actin from the clot may restore the clot's rheologic properties and render it more sensitive to the lytic action of plasmin.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1323346

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  10 in total

1.  Recombinant Human Plasma Gelsolin Improves Survival and Attenuates Lung Injury in a Murine Model of Multidrug-Resistant Pseudomonas aeruginosa Pneumonia.

Authors:  Mark J DiNubile; Susan L Levinson; Thomas P Stossel; Matthew B Lawrenz; Jonathan M Warawa
Journal:  Open Forum Infect Dis       Date:  2020-06-19       Impact factor: 3.835

2.  Systemic hyperfibrinolysis after trauma: a pilot study of targeted proteomic analysis of superposed mechanisms in patient plasma.

Authors:  Anirban Banerjee; Christopher C Silliman; Ernest E Moore; Monika Dzieciatkowska; Marguerite Kelher; Angela Sauaia; Kenneth Jones; Michael P Chapman; Eduardo Gonzalez; Hunter B Moore; Angelo D'Alessandro; Erik Peltz; Benjamin E Huebner; Peter Einerson; James Chandler; Arsen Ghasabayan; Kirk Hansen
Journal:  J Trauma Acute Care Surg       Date:  2018-06       Impact factor: 3.313

3.  Fibrinolytic PLGA nanoparticles for slow clot lysis within abdominal aortic aneurysms attenuate proteolytic loss of vascular elastic matrix.

Authors:  Balakrishnan Sivaraman; Andrew Sylvester; Anand Ramamurthi
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2015-09-16       Impact factor: 7.328

4.  Safety and Pharmacokinetics of Recombinant Human Plasma Gelsolin in Patients Hospitalized for Nonsevere Community-Acquired Pneumonia.

Authors:  Abla Tannous; Susan L Levinson; James Bolognese; Steven M Opal; Mark J DiNubile
Journal:  Antimicrob Agents Chemother       Date:  2020-09-21       Impact factor: 5.191

5.  Protective effects of gelsolin in acute pulmonary thromboembolism and thrombosis in the carotid artery of mice.

Authors:  Ashok Kumar Gupta; Bhupinder Singh Chopra; Bhavna Vaid; Amin Sagar; Sachin Raut; Maulik D Badmalia; Neeraj Khatri
Journal:  PLoS One       Date:  2019-04-19       Impact factor: 3.240

6.  Commentary: Is There a Crucial Link Between Vitamin D Status and Inflammatory Response in Patients With COVID-19?

Authors:  Marijn M Speeckaert; Joris R Delanghe
Journal:  Front Immunol       Date:  2022-03-22       Impact factor: 7.561

7.  Adjunctive Recombinant Human Plasma Gelsolin for Severe Coronavirus Disease 2019 Pneumonia.

Authors:  Mark J DiNubile; Sandra Parra; Antoni Castro Salomó; Susan L Levinson
Journal:  Open Forum Infect Dis       Date:  2022-07-25       Impact factor: 4.423

8.  BDNFVal66met polymorphism: a potential bridge between depression and thrombosis.

Authors:  Patrizia Amadio; Gualtiero I Colombo; Eva Tarantino; Sara Gianellini; Alessandro Ieraci; Maura Brioschi; Cristina Banfi; José P Werba; Alessandro Parolari; Francis S Lee; Elena Tremoli; Silvia S Barbieri
Journal:  Eur Heart J       Date:  2017-05-07       Impact factor: 29.983

9.  Investigation of the actin scavenging system in pre-eclampsia.

Authors:  Dionne S Tannetta; Christopher W Redman; Ian L Sargent
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2013-10-25       Impact factor: 2.435

10.  Acute Lung Injury in Critically Ill Patients: Actin-Scavenger Gelsolin Signals Prolonged Respiratory Failure.

Authors:  Freja Stæhr Holm; Pradeesh Sivapalan; Niels Seersholm; Theis Skovsgaard Itenov; Per Hjort Christensen; Jens-Ulrik Stæhr Jensen
Journal:  Shock       Date:  2019-09       Impact factor: 3.454

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.